Parnassus Investments LLC Acquires 185 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Parnassus Investments LLC grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,318 shares of the medical equipment provider’s stock after acquiring an additional 185 shares during the quarter. Parnassus Investments LLC’s holdings in Intuitive Surgical were worth $1,210,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of ISRG. Massachusetts Financial Services Co. MA bought a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $558,807,000. Proficio Capital Partners LLC boosted its position in shares of Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after acquiring an additional 948,902 shares during the period. FMR LLC boosted its position in shares of Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after acquiring an additional 838,793 shares during the period. Raymond James Financial Inc. bought a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $313,769,000. Finally, Wilmington Savings Fund Society FSB raised its stake in shares of Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after purchasing an additional 552,058 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Truist Financial upped their target price on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Royal Bank of Canada upped their target price on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Barclays upped their target price on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Jefferies Financial Group upped their target price on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, Stifel Nicolaus upped their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Activity

In related news, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 33,754 shares of company stock worth $17,691,621. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $484.44 on Friday. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The firm has a market cap of $172.55 billion, a PE ratio of 75.58, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The business has a fifty day moving average of $567.46 and a 200-day moving average of $531.26.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.